# Clearance of 25-hydroxyvitamin D in Cystic Fibrosis

> **NCT03104855** · PHASE1 · COMPLETED · sponsor: **University of Washington** · enrollment: 10 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** d6-25-hydroxyvitamin D3

## Key facts

- **NCT ID:** NCT03104855
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-03
- **Primary completion:** 2018-10-09
- **Final completion:** 2023-09-06
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03104855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03104855, "Clearance of 25-hydroxyvitamin D in Cystic Fibrosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03104855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*